Overview

Safinamide in Levodopa Induced Dyskinesia in Parkinson's Disease Subjects

Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
Approximately twenty four (24) subjects will participate in this research trial. The research trial will be conducted in approximately twelve (12) medical centers in the following countries: Germany, France, South Africa, Austria and Canada. The research trial will last until December 2011.
Phase:
Phase 2
Details
Lead Sponsor:
Newron
Newron Pharmaceuticals SPA
Treatments:
Levodopa